Antiphospholipid Syndrome clinical trials at University of California Health

2 research studies open to eligible people

Showing trials for

  • RAY121 in Immunological Diseases (RAINBOW Trial)

    open to eligible people ages 18-85

    This Phase 1b basket trial will investigate the safety, tolerability, pharmacokinetics, pharmacodynamics, immunogenicity and preliminary efficacy of RAY121, a inhibitor of classical complement pathway, after multiple dose administration in patients with immunological diseases such as antiphospholipid syndrome (APS), bullous pemphigoid (BP), Behçet's Syndrome (BS), dermatomyositis (DM), immune-mediated necrotizing myopathy (IMNM) and immune thrombocytopenia (ITP).

    at UC Irvine

  • Register for Pediatric Patients With Antiphospholipid Syndrome (APS): European Project Extended Internationally Study

    “This research study will take a look at Antiphospholipid Syndrome in order to learn how to better diagnose and control it.”

    open to eligible people ages up to 18 years

    The purpose of this study is to gather information about causes and treatment of Antiphospholipid Syndrome.

    at UC Davis

Our lead scientists for Antiphospholipid Syndrome research studies include .

Last updated: